Tag: FSI-189

Gilead Sciences to acquire immuno-oncology company Forty Seven for $4.9bn

pharmanewsdaily- March 3, 2020

Gilead Sciences acquisition of Forty Seven : US biotech company Gilead Sciences has signed an all-cash deal worth around $4.9 billion to acquire Forty Seven, ... Read More